- Janssen Products LP
- Johnson & Johnson
- Animas Corp.
- Egea Biosciences Inc.
- Vascular Control Systems Inc.
- Zosano Pharma Corp.
- Alza Corp.
- Scios Inc.
- Barrier Therapeutics Inc.
- Movetis NV
- NovaVision Inc.
- Johnson & Johnson Vision Care Inc.
- DePuy Synthes Spine Inc.
- Archus Orthopedics Inc.
- Five Prime Therapeutics Inc.
- PhaseBio Pharmaceuticals Inc.
- J&J buys Animas
- Johnson & Johnson buys alliance partner Egea Biosciences
- J&J acquires TransForm Pharmaceuticals for $230mm in cash
- J&J's Ethicon acquires Vascular Control Systems
- J&J's Alza spins off drug delivery company Macroflux
- Barrier Therapeutics grosses $46mm with Series B financing
- Series A raises €49mm for Movetis NV
- Series C raises $20mm for eye device start-up NovaVision
- Archus closes $35mm Series C round
- Centocor gets exclusive rights to FivePrime compounds
- Series B round for Phase Bioscience raises $25mm; closed at $48.4mm
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.